Where Zimbabwe Stands in the Fight Against HIV
Michael Gwarisa In 1985, Zimbabwe recorded its first confirmed case of HIV, marking the start of a national epidemic. By the mid-1980s, cases were rising rapidly, particularly in Hurungwe District, where formal surveillance began in 1986. By the end of the decade, nearly 10 percent of Zimbabwe’s adult population had already been infected. Nearly four
Read More
Study Finds Toxic Chemicals in Menstrual Pads May Affect Hormones and Raise Health Risks
Michael Gwarisa For many women, sanitary pads are an essential part of daily life. They help manage menstrual hygiene and keep women comfortable and active. But a recent South African study has revealed a hidden risk, some pads and panty liners may contain chemicals that interfere with hormones and could increase long-term health risks, including
Read More
Coalition Warns Clause 11 Deletion Leaves Women Facing Bureaucratic Barriers
Kuda Pembere A coalition of girls’ rights and health advocates has condemned the deletion of Clause 11 from the Medical Services Amendment Bill, arguing that the decision preserves outdated administrative hurdles that continue to obstruct women and girls from accessing legal abortion care. Following the deletion of Clause 11 from the Medical Services Amendment Bill,
Read More
Why Obesity Causes Chronic Inflammation in Millions of Americans
Michael Gwarisa More than one in three American adults lives with obesity, and scientists have long known it fuels chronic inflammation linked to diabetes, heart disease, and fatty liver. Now, an NIH-funded study has uncovered the biological chain reaction behind this process, opening the door to new treatments beyond weight loss. New research funded by
Read More
Japanese Study Identifies Genetic Mismatch That Triples Risk of Life-Threatening Complications After Cord Blood Transplant
Michael Gwarisa More than 7,400 patients in Japan have contributed to a breakthrough study identifying a hidden genetic mismatch that significantly increases the risk of life-threatening immune complications after umbilical cord blood transplantation. The research, led by Associate Professor Takakazu Kawase of Fujita Health University and the Japanese Society for Transplantation and Cellular Therapy (JSTCT)
Read More
Advanced Blood Screening Technology Commissioned at NBSZ
Kuda Pembere The Government of Zimbabwe has commissioned a Nucleic Acid Testing (NAT) machine at the National Blood Service Zimbabwe (NBSZ), a development expected to significantly reduce turnaround times and enhance the safety of blood transfusions. Speaking at the commissioning ceremony, Health and Child Care Minister Dr Douglass Mombeshora described the installation as not only
Read More
Zimbabwe Launches Revolutionary HIV Prevention Program with Lenacapavir
Watch: Zimbabwe Launches Lenacapavir: New HIV Prevention Injection With 99.9% Protection Michael Gwarisa In a major step forward for HIV prevention, Zimbabwe has officially launched the rollout of Lenacapavir, a long-acting injectable drug that provides new protection options for communities at high risk of HIV infection. Zimbabwe joins South Africa, Kenya, Zambia, and Eswatini among
Read More
Senate Approves Medical Services Amendment Bill After Deleting Clause 11
Michael Gwarisa After days of speculation and heightened public debate, Zimbabwe’s Medical Services Amendment Bill [H.B. 6A, 2025] has passed Parliament, but without the contentious Clause 11, which was formally deleted during the legislative process. The Bill was considered during the Committee Stage in the Parliament of Zimbabwe, where Clauses 1 to 10 were approved
Read More
Africa CDC and FHI 360 Sign MoU to Strengthen Health Security and Advance Africa’s Health Sovereignty
Michael Gwarisa In a move aimed at strengthening collaboration to advance health security, workforce development, and resilient public health systems across Africa, the Africa Centres for Disease Control and Prevention has signed a Memorandum of Understanding (MoU) with FHI 360. The MoU sets in motion a structured framework for cooperation aligned with Africa CDC’s Strategic
Read More
What the Science Says About Lenacapavir, Its Effectiveness, Side Effects and Zimbabwe’s HIV Prevention Push
Michael Gwarisa Zimbabwe has set the stage for the rollout of Lenacapavir, a long acting injectable HIV prevention medicine that is expected to significantly strengthen the country’s HIV response. The injectable drug, which is administered only twice a year, is being introduced as part of Zimbabwe’s expanded HIV prevention strategy targeting people at high risk
Read More